News

Tramway Venture Partners

How The BioScience Center is helping New Mexico’s tech industry thrive

Technology continues to advance extremely quickly across the globe, and that is no different here in New Mexico. Some of the major growth that the Land of Enchantment is seeing…

Read More...

Tramway Ventures lands state boost for new $40M fund

By Jacob Maranda – New Mexico Inno Reporter September 19, 2023, 05:12pm MDT   There could soon be a lot more venture capital flowing into New Mexico companies thanks to…

Read More...

Tramway Ventures Welcomes Chris Japp as Managing Partner

[Albuquerque, August 21, 2023] – Tramway Ventures, New Mexico’s leading life sciences and healthcare venture capital firm, proudly announces the appointment of Chris Japp as Managing Partner to the firm….

Read More...

Armonica Technologies

UNM Technology Accelerates Genomic Sequencing

Today, DNA sequencing is a tortuous process that often takes days and sometimes weeks to read a full human genome, but University of New Mexico researchers may have found a…

Read More...

Pushing the Boundaries of DNA Sequencing

A young company developing technology created at the University of New Mexico (UNM) is on a mission to disrupt the landscape of DNA sequencing. Armonica Technologies, LLC, is developing a…

Read More...

BennuBio

BennuBio Receives SLAS 2022 Ignite Award

February 27, 2022 BennuBio announced it received the Society for Laboratory Automation and Screening (SLAS) prestigious Ignite award at SLAS’s annual International Conference and Exhibition in Boston, MA on February…

Read More...

BennuBio Hires Matthew Hess as COO

BennuBio has hired Matthew Hess as Chief Operations Officer. He has over 20 years experience helping start-up companies bring technology to market. With a background in software engineering and experience…

Read More...

BennuBio moves into larger facility

In response to continuing success of their novel large particle flow cytometer, BennuBio has moved to a larger facility to consolidate engineering, administrative and laboratory in one building. Formerly located…

Read More...

Circular Genomics

Circular Genomics Announces Launch of MindLight™, the First SSRI Antidepressant Response Test Using Brain-Derived Biomarkers

ALBUQUERQUE, N.M., Sept. 16, 2024 /PRNewswire/ — Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry and neurology, today announced the launch of MindLight, the first circular…

Read More...

Circular Genomics Adds Dr. Michael Ackermann, PhD, MBA to its Scientific Advisory Board

ALBUQUERQUE, N.M., March 18, 2024 /PRNewswire/ — Circular Genomics, the global leader in circular RNA biomarkers for precision psychiatry and neurology, today announced the addition of Michael F. Ackermann, PhD,…

Read More...

Circular Genomics Strengthens Leadership Team with Key Commercial and Research Hires

ALBUQUERQUE, N.M., Feb. 26, 2024 /PRNewswire/ — Circular Genomics, the global leader in advancing circular RNA biomarkers for precision psychiatry and neurology, today announced the appointments of Dave Karlander as…

Read More...

WaveDyn Vision

Senior Ophthalmology Executive Thomas A. (Tom) Dunlap Joins WaveFront Dynamics Inc. as an Independent Member of the Board of Directors to Support the Company’s Ongoing Commercialization and Broader Strategic Initiatives

ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WDI), a venture backed company and pioneer in wavefront sensing technology for use in measuring and perfecting visual performance, today announced the appointment of Tom…

Read More...

WaveFront Dynamics Inc. Launches WaveDȳn® Vision Analyzer

ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc., an ophthalmic medical device company, announced today the commercial launch of its dynamic aberrometry measurement system, the WaveDyn Vision Analyzer. The WaveDyn Vision Analyzer (pronounced…

Read More...

WaveFront Dynamics Inc. Initiates $3mm Series A Round to Fund Continued Development of Dynamic Wavefront Measurement System for Vision Correction

ALBUQUERQUE, N.M.–(BUSINESS WIRE)–WaveFront Dynamics Inc. (WaveDyn™), an early stage ophthalmic medical device company, today announced the first close of a $3 million Series A financing round. The round was led by…

Read More...

Vitazi.ai

Vitazi.ai Creates a Platform to Deliver Artificial Intelligence to Improve Physician Efficiency and Diagnostics Accuracy

    Vitazi.ai is reimagining image-based diagnostics so providers can gain higher quality, real time & trustable health insights.  October 8, 2021  Albuquerque, New Mexico — Today Tramway Venture Partners…

Read More...